Connor, Clark & Lunn Investment Management (CC&L)
BLUE

Connor, Clark & Lunn Investment Management (CC&L)’s bluebird bio BLUE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,744
Closed -$393K – 1117
2022
Q2 		$393K Buy
4,744
+2,125
+81% +$165K ﹤0.01% 826
2022
Q1 		$254K Buy
+2,619
New +$346K ﹤0.01% 906
2021
Q4 		– Sell
-5,859
Closed -$1.45M – 1085
2021
Q3 		$1.45M Sell
5,859
-790
-12% -$226K 0.01% 581
2021
Q2 		$2.75M Buy
6,649
+5,102
+330% +$2.02M 0.01% 480
2021
Q1 		$604K Buy
+1,547
New +$762K ﹤0.01% 768
2020
Q2 		– Sell
-1,231
Closed -$733K – 1020
2020
Q1 		$733K Buy
1,231
+943
+327% +$919K 0.01% 625
2019
Q4 		$327K Buy
+288
New +$313K ﹤0.01% 747
2015
Q3 		– Sell
-1,463
Closed -$3.19M – 720
2015
Q2 		$3.19M Sell
1,463
-4,945
-77% -$10.1M 0.03% 193
2015
Q1 		$10M Buy
6,408
+2,046
+47% +$2.7M 0.08% 111
2014
Q4 		$5.18M Buy
4,362
+3,899
+842% +$2.61M 0.04% 149
2014
Q3 		$215K Buy
+463
New +$214K ﹤0.01% 486

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BLUE Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 4,744 shares — an estimated $393K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BLUE in Q3 2014 and held it in 11 quarters. The position peaked at $10M in Q1 2015. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 4,744 bluebird bio shares in Q3 2022, an estimated $393K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in bluebird bio in Q3 2014 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s bluebird bio position peaked at $10M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.